Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonization

Clinical and Vaccine Immunology

Volumn 21, Issue 9, 2014, Pages 1277-1281

  Juergens, Christine ^a   Patterson, Scott ^a   Trammel, James ^b   Greenberg, David ^c   Givon Lavi, Noga ^c,d   Cooper, David ^a   Gurtman, Alejandra ^a   Gruber, William C ^a   Scott, Daniel A ^a   Dagan, Ron ^c  

^a PFIZER INC   (United States)

^b SYNEOS HEALTH   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE; BACTERIUM ANTIBODY; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; OPSONIN;

AGE DISTRIBUTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG CROSS REACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INFANT; ISRAELI; MALE; NASOPHARYNX; NORMAL HUMAN; OPSONIZATION; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; ANTIBODY PRODUCTION; BLOOD; CLASSIFICATION; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; ISRAEL; MICROBIOLOGY; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTIONS; PREVENTION AND CONTROL;

ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; CARRIER STATE; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; INFANT; ISRAEL; MALE; NASOPHARYNX; OPSONIN PROTEINS; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROGROUP; STREPTOCOCCUS PNEUMONIAE;

EID: 84933548512     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00172-14     Document Type: Article

References (14)

1. Dagan R, Patterson S, Juergens C, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA. 2013. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin. Infect. Dis. 57:952-962. http://dx.doi.org/10.1093/cid/cit428.
2. Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P, Jansen KU. 2011. The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Vaccine 29:7207-7211. http://dx.doi.org/10.1016/j.vaccine. 2011.06.056.
3. Hu BT, Yu X, Jones TR, Kirch C, Harris S, Hildreth SW, Madore DV, Quataert SA. 2005. Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 12:287-295. http://dx.doi.org/10.1128/CDLI.12.2.287-295.2005. (Pubitemid 41094454)
4. Yeh SH, Gurtman A, Hurley DC, Block SL, Schwartz RH, Patterson S, Jansen KU, Love J, Gruber WC, Emini EA, Scott DA, 004 Study Group. 2010. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers. Pediatrics 126:e493- e505. http://dx.doi.org/10.1542/peds.2009-3027.
5. Kim DS, Shin SH, Lee HJ, Hong YJ, Lee SY, Choi KM, Oh CE, Kim KH, Juergens C, Patterson S, Giardina PC, Gruber WC, Emini EA, Scott DA. 2013. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given to Korean children receiving routine pediatric vaccines. Pediatr. Infect. Dis. J. 32:266-273. http://dx.doi.org/10.1097/INF.0b013e3182748bb6.
6. Väkeväinen M, Jansen W, Saeland E, Jonsdottir I, Snippe H, Verheul A, Käyhty H. 2001. Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable? Clin. Diagn. Lab. Immunol. 8:363-369. http://dx.doi.org/10.1128/ CDLI.8.2.363-369.2001. (Pubitemid 32217070)
7. Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A. 2006. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368:1495-1502. http://dx.doi.org/10.1016/S0140- 6736(06)69637-2. (Pubitemid 44634693)
8. Lee LH, Frasch CE, Falk LA, Klein DL, Deal CD. 2003. Correlates of immunity for pneumococcal conjugate vaccines. Vaccine 21:2190-2196. http://dx.doi.org/10.1016/S0264-410X(03)00025-2.
9. World Health Organization. 2013. Annex 3: recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines. Replacement of WHOtechnical report series, no. 927, annex 2. World Health Organization, Geneva, Switzerland. http://www.who.int/biologicals/vaccines/TRS-977-Annex-3.pdf.
10. Goldblatt D, Hussain M, Andrews N, Ashton L, Virta C, Melegaro A, Pebody R, George R, Soininen A, Edmunds J, Gay N, Kayhty H, Miller E. 2005. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J. Infect. Dis. 192:387-393. http://dx.doi.org/10. 1086/431524. (Pubitemid 41023116)
11. Klugman K, Black S, Dagan R, Malley R, Whitney CG. 2012. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines, p 534-535. In Plotkin SA, Orenstein WA, (ed). Vaccines, 6th ed. Saunders, Philadelphia, PA.
12. Lundgren A, Bhuiyan TR, Novak D, Kaim J, Reske A, Lu YJ, Qadri F, Malley R. 2012. Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country. Vaccine 30:3897-3907. http://dx.doi.org/10.1016/j.vaccine.2012.03.082.
13. Le Polain de Waroux O, Flasche S, Prieto-Merino D, Edmunds WJ. 2014. Age-dependent prevalence of nasopharyngeal carriage of Streptococcus pneumoniae before conjugate vaccine introduction: a prediction model based on a meta-analysis. PLoS One 9:e86136. http://dx.doi.org/10.1371/journal.pone. 0086136.
14. Dagan R, Givon-Lavi N, Fraser D, Lipsitch M, Siber GR, Kohberger R. 2005. Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J. Infect. Dis. 192:367-376. http://dx.doi.org/10.1086/431679. (Pubitemid 41023114)